ES8404361A1 - Un procedimiento para la preparacion de un derivado de cefalosporina. - Google Patents

Un procedimiento para la preparacion de un derivado de cefalosporina.

Info

Publication number
ES8404361A1
ES8404361A1 ES515548A ES515548A ES8404361A1 ES 8404361 A1 ES8404361 A1 ES 8404361A1 ES 515548 A ES515548 A ES 515548A ES 515548 A ES515548 A ES 515548A ES 8404361 A1 ES8404361 A1 ES 8404361A1
Authority
ES
Spain
Prior art keywords
group
furopyridinium
thieno
relating
cephalosporin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515548A
Other languages
English (en)
Other versions
ES515548A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8404361A1 publication Critical patent/ES8404361A1/es
Publication of ES515548A0 publication Critical patent/ES515548A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO DE CEFALOSPORINA, DE FORMULA GENERAL (I), EN LA QUE R ES HIDROGENO O UN GRUPO ACILO; R ES UN GRUPO BICICLOPIRIDINIO SELECCIONADO ENTRE UN GRUPO TIENOPIRIDINIO Y UN GRUPO FUROPIRIDINIO, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN SOMETER A UNA REACCION DE CONDENSACION UN COMPUESTO DE FORMULA (II), EN LA QUE L ES UN GRUPO SALIENTE; Y R3 ES HIDROGENO O UN GRUPO PROTECTOR DE ESTER, CON UNA TIENO O FUROPIRIDINA.DE APLICACION EN COMPOSICIONES FARMACEUTICAS UTILIZADAS EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS.
ES515548A 1981-09-08 1982-09-07 Un procedimiento para la preparacion de un derivado de cefalosporina. Granted ES515548A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30035781A 1981-09-08 1981-09-08
US34062882A 1982-01-19 1982-01-19

Publications (2)

Publication Number Publication Date
ES8404361A1 true ES8404361A1 (es) 1984-04-16
ES515548A0 ES515548A0 (es) 1984-04-16

Family

ID=26971737

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515548A Granted ES515548A0 (es) 1981-09-08 1982-09-07 Un procedimiento para la preparacion de un derivado de cefalosporina.
ES527763A Granted ES527763A0 (es) 1981-09-08 1983-12-02 Un procedimiento para la preparacion de un derivado de cefalosporina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES527763A Granted ES527763A0 (es) 1981-09-08 1983-12-02 Un procedimiento para la preparacion de un derivado de cefalosporina

Country Status (17)

Country Link
EP (1) EP0074268A3 (es)
KR (1) KR840001585A (es)
CS (1) CS232735B2 (es)
DD (1) DD209633A5 (es)
DK (1) DK399282A (es)
ES (2) ES515548A0 (es)
FI (1) FI823088L (es)
GB (1) GB2105719A (es)
GR (1) GR76701B (es)
HU (1) HU187575B (es)
IL (1) IL66726A0 (es)
NZ (1) NZ201833A (es)
PH (1) PH19756A (es)
PL (1) PL238158A1 (es)
PT (1) PT75518B (es)
RO (1) RO84456B (es)
SU (1) SU1169542A3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097961B1 (en) * 1982-06-28 1987-11-11 Bristol-Myers Company Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
US4480098A (en) * 1982-11-12 1984-10-30 Eli Lilly And Company Preparation of alkali metal thieno(furo)pyridines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
EP0137442A3 (de) * 1983-10-08 1986-01-15 Hoechst Aktiengesellschaft Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0138552A3 (en) * 1983-10-17 1986-03-19 Eli Lilly And Company Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
EP0182633A3 (en) * 1984-11-20 1987-09-02 Ici Pharma Cephalosporin derivatives
EP0187456A1 (en) * 1984-11-29 1986-07-16 Ici Pharma Cephalosporin derivatives
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
BR0107645A (pt) * 2000-02-10 2002-10-08 Upjohn Co Oxazolidinona tiamidas com substituintes de piperazina amida
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
DE602004028111D1 (de) 2003-04-16 2010-08-26 Sandoz Ag Verfahren zur herstellung von cefepim

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2760484C2 (es) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"

Also Published As

Publication number Publication date
GR76701B (es) 1984-08-29
KR840001585A (ko) 1984-05-07
PT75518B (en) 1985-11-12
ES8505374A1 (es) 1985-05-16
DK399282A (da) 1983-03-09
CS650582A2 (en) 1984-06-18
FI823088L (fi) 1983-03-09
ES527763A0 (es) 1985-05-16
CS232735B2 (en) 1985-02-14
NZ201833A (en) 1985-09-13
IL66726A0 (en) 1982-12-31
RO84456B (ro) 1984-08-30
PL238158A1 (en) 1984-11-19
DD209633A5 (de) 1984-05-16
FI823088A0 (fi) 1982-09-07
HU187575B (en) 1986-01-28
ES515548A0 (es) 1984-04-16
EP0074268A2 (en) 1983-03-16
RO84456A (ro) 1984-06-21
PH19756A (en) 1986-06-26
SU1169542A3 (ru) 1985-07-23
GB2105719A (en) 1983-03-30
EP0074268A3 (en) 1984-05-23
PT75518A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ATE4903T1 (de) 1-, 6- und 2-substituierte 1-carba-2-penem-3carbons[ure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AU538424B2 (en) Piperazino phenylindane
JPS5412372A (en) Thiazolidine derivative and its preparation
ES474289A1 (es) Un procedimiento para la preparacion de derivados del acido 6-(1'-hidroxietil)-7-oxi-1-aza-biciclo(3,2,0)hept-2-en -2- carboxilico-3-sustutuidos
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
SE8801514D0 (sv) Farmaceutisk komposition
ES8403877A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
ES8505207A1 (es) Un procedimiento para la preparacion de una macrolida
ES8506726A1 (es) Un procedimiento para la fabricacion de un nuevo compuesto de cefalosporina.
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
ES2001852A6 (es) Procedimiento para preparar un derivado de acido quinolocarboxilico
ES8506731A1 (es) Un procedimiento para preparar derivados de cefalosporina
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
ES8303418A1 (es) Un procedimiento para la preparacion de derivados de benzo (4,5 pinano 2,3c) pirrol.
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
AU557880B2 (en) Method for modulating the immune response with dibenzocycloheptenylidenes
IE790754L (en) Substituted ethanolamines
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE92461T1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten